Results 151 to 160 of about 29,136 (254)

Heterologous vaccination interventions to reduce pandemic morbidity and mortality: Modeling the US winter 2020 COVID-19 wave. [PDF]

Proc Natl Acad Sci U S A, 2022
Hupert N, Marín-Hernández D, Gao B, Águas R, Nixon DF.   +4 more
europepmc   +1 more source

DAMPs, PAMPs, and Alarmins: From Mechanism to Therapy

MedComm, Volume 7, Issue 9, September 2026.
This review synthesizes the expanding biology of PAMPs and DAMPs, from their molecular sources and sensing mechanisms to regulatory networks that govern inflammation and homeostasis. Spanning from classical immune activation to trained immunity and interorgan communication, we highlight the interplay between PAMPs and DAMPs and their context‐dependent ...
Xuanxuan Yu, Yuqin Jin, Baochao Li, Jie Deng, Yiwen Zhou, Jinglun Zhang, Huang Li   +6 more
wiley   +1 more source

Relationship between anthropometric and body composition parameters and anti-SARS-CoV-2 specific IgG titers in females vaccinated against COVID-19 according to the heterologous vaccination course: A cohort study. [PDF]

PLoS One, 2023
Golec M, Zembala-John J, Fronczek M, Konka A, Bochenek A, Wystyrk K, Botor H, Zalewska M, Chrapiec M, Kasperczyk S, Brzoza Z, Bułdak RJ.   +11 more
europepmc   +1 more source

Facile, high‐throughput protein purification enabled by high‐efficiency protease elution

Protein Science, Volume 35, Issue 9, September 2026.
Abstract While advances in artificial intelligence have made protein design widely accessible, protein production and characterization remain a bottleneck. Protease‐cleavable affinity tags are commonly used to improve yield and purity of recombinant proteins, but tag removal adds labor and complexity.
Edson N. Cárcamo Noriega, Ian S. Truebridge, Frank D. Teets III, James W. Bowman III, Nathalia Rodriguez, Tessa A. Howard, Christopher D. Bahl   +6 more
wiley   +1 more source

Comparison of homologous and heterologous vaccination strategies for combating disease caused by <i>Burkholderia pseudomallei</i>. [PDF]

Front Immunol
Biryukov SS, Cote CK, Klimko CP, Dankmeyer JL, Rill NO, Hunter M, Davies ML, Hedrick ZM, Shoe JL, Schmidt LK, Orne CE, Qiu J, Welkos SL, Burtnick MN, Brett PJ, DeShazer D.   +15 more
europepmc   +1 more source

Structure and conformational dynamics of the Pseudomonas CbrA transceptor

Protein Science, Volume 35, Issue 9, September 2026.
Abstract The CbrA protein is a central regulator of carbon metabolism, biofilm formation, and virulence in Pseudomonas species, but the molecular mechanisms by which CbrA links nutrient sensing to downstream signaling has remained unclear. CbrA is a rare “transceptor” that combines membrane transporter and histidine kinase domains into a single ...
Melanie A. Orlando, Tejas Shah, Matthew W. Faber, Samik Bose, Benjamin J. Orlando   +4 more
wiley   +1 more source

Homologous and Heterologous Vaccination Regimens with mRNA and rVSV Platforms Induce Potent Immune Responses Against SFTSV Glycoprotein. [PDF]

Viruses
Manzoni TB, Westover JB, Lundgreen KA, Hicks PD, Petch RJ, Ort JT, Weissman D, Fan SHY, Hensley SE, Pardi N, Gowen BB, Bates P.   +11 more
europepmc   +1 more source

Higher SARS-CoV-2 Spike Binding Antibody Levels and Neutralization Capacity 6 Months after Heterologous Vaccination with AZD1222 and BNT162b2. [PDF]

Vaccines (Basel), 2022
Müller-Hilke B, Mai F, Müller M, Volzke J, Reisinger EC.   +4 more
europepmc   +1 more source

Nanotechnology‐Based Immunostimulants in Aquaculture: Mechanisms, Advances and Practical Applications

Veterinary Medicine and Science, Volume 12, Issue 5, September 2026.
Nano‐immunostimulants improve fish health through targeted and controlled delivery of immunostimulatory compounds. Biodegradable polymeric and lipid‐based nanocarriers enhance immune responses, bioavailability and disease resistance while reducing antibiotic dependence and environmental impact.
Mustafa Öz, Enes Üstüner
wiley   +1 more source

Efficacy of Heterologous Vaccination Using Virus-Like Particles and Vaccinia Virus Containing MIC8 and AMA1 Proteins of <i>Toxoplasma gondii</i>. [PDF]

Vaccines (Basel)
Kang HJ, Quan FS.
europepmc   +1 more source